Dr. Hamed Alavi

Dr. Hamed Alavi

Senior Vice President & Chief Technology OfficeratenVVeno Medical· In proxies 2022–2025

Pay in FY2023-8% from the year before · enVVeno Medical stock +0.8% the same year

Dr. Hamed Alavi was paid $669.2K in FY2023 (Dec), down 8%. enVVeno Medical stock rose 0.8% that year.

Pay$100 in the stock at the end of FY21 → $78
Pay is from the Summary Compensation Table of each enVVeno Medical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. enVVeno MedicalPublic company · 4 yr
    • Senior Vice President & Chief Technology Officer2022 – Present · 4 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?